BSEResult2d ago · 13 Nov 2026, 04:58 pm

Financial Results for the quarter and half year ended 30th September, 2026

3B BlackBio Dx Ltd · 532067

✦ AI Summary▲ PositiveResults

3B BlackBio Dx Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026. The company's revenue from operations was ₹5,645.17 crore for the half year, with a profit before tax of ₹4,258.82 crore. The company's earnings per equity share for the half year was ₹37.43.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

3B BlackBio Dx Ltd - 532067 - Financial Results For The Quarter And Half Year Ended 30Th September, 2026

Attachments (1)

📄

f91ec54b-5fed-40cb-b7e9-612e2a64de95.pdf

pdf

Download →
View document text
(Formerly Kilpest India Limited) Ref. No.P-66/2026-27/52 November 13, 2026 The Relationship Manager, Department of Corporate Relations BSE Limited, P.J. Towers, Dalal Street Fort, MUMBAI 400 001 Subject: Outcome of Board Meeting held on Friday, 13th November, 2026 Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that, the Board of Directors of the Company at its Meeting held today i.e. 13th November, 2026, have inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September 2026 along with Statement of Assets and Liabilities as at 30th September 2026 (Standalone and Consolidated) and Statement of Cash Flow for the half year ended on 30th September 2026 (Standalone and Consolidated). The same has also been reviewed by the Audit Committee in its meeting held earlier today. Further, M/s Baheti & Co., Statutory Auditors of the Company have carried out the Limited Review of the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2026 and the Board has also taken on record their Limited Review Reports on the said Financial Results. A copy of the Limited Review Reports along with the Financial Results is enclosed herewith. The meeting of the Board of Directors commenced at 3:00 p.m. and concluded at 3:45 p.m. You are requested to take the same on record. Thanking You, For 3B BlackBio Dx Limited (Formerly, Kilpest India Limited) Nikhil Kuber Dubey Whole Time Director DIN: 00538049 Encl: As above Regd. Office & Factory:7-C | Industrial Area | Govindpura | Bhopal 462023 | (M.P.) | INDIA CIN : L24211MP1972PLC001131 Ph.:91-755-2586536, 2586537 Email :info@kilpest.com Visit us at :www.kilpest.com . M/s 38 BI.ACKBIO Dx tTD (FormerlY M/s KILPEST ,NDIA LTD) REGD.OFFICE: 7-C, INDUSTRIAL AREA,GOVINDPURA, BHOPAT-462 023 Cl N:124211MP1972P1c001131 SNo PARTICULARS QUARTER ENDED HALFYEAR ENDED YEAR ENDED 30-09-2025 30-06-2026 30-09-2025 30-o9-2026 30-09-2025 3L-O3-2026 (unauditedl (unaudited) (unaudited (unaudited) (unaudited (AUDITED) I Revenue from operations 3650.65 2294.52 279t.L6 5945.L7 4826.81 9727.50 Other income 246.20 530.21 391.31 776.47 822.73 t4L6.2C Total Income (l + ll) 3896.85 2824.79 3182.47 672r.64 5549.6C LLr43.tC Expenses: Cost of materials consumed 813.01 493 25 683.11 1306.26 L202.8t 2345.16 )urchases of Stock-in-Trade 000 0.00 0.00 0.0c 0.00 000 Changes in inventories of t9.22 lze.s4l 642 (t0.72) 045 11.69 fi nished goods work-in-progress and Stock-in-Trade Emplovee benefits expenses 247.05 182.86 2L5.63 429.97 364.44 757.93 Finance costs 004 o.o2 120 0.06 2.00 4.39 Depreciation and amortization exDense 23.5C 23.5C 2I.50 47.00 43.00 94.31 Other expenses 370.53 3r9.72 302.27 590.31 516.62 1294.54 Total expenses (lV) L473.35 989.47 1230.13 2462.82 2L29.32 4508.02 Profi t/(loss) before exceptiona I 2423.50 1835.32 1952.34 3520.28 6635.68 items and tax (lll - lV) v Exceptional items 0.00 0.00 0.0c 000 0.0c 0.00 Profit before tax N - Vll 2423.5C 1835.32 1952.34 4258.82 3520.22 6635.68 Tax exoense: l1) Current tax 627.36 424.!L 45826 !051.47 780.tt 1515.45 l2l Deferred tax 0.00 0.00 000 000 0.00 88.50 Profit (Loss) forthe period (Vll- X vilr) 1796.L4 L4TI.2L 1494.08 3207.35 2740.t2 4931.69 Other Comprehensive Income/(loss) X 000 00c 0.00 0.00 0.00 0.00 Total Comprehensive Income for X the period (lX+X) 1796.L4 r47L.2l 1494.08 3207.3s 2740pL2 4931.69 X Paid-up Equitv Share capital 856.84 856.84 856.84 856.84 856.84 856.84 Reserve excluding Revaluation Reserves as per balance sheet of X orevtous vear 3LO44.75 3L044.75 2642!.76 31044.75 26421.76 2642t.7e XV Earnings per equity share: 1) Basic 20.96 16.47 17.44 37.43 31.98 57.5e (2) Diluted 20.95 L6.47 L7.44 37.43 31 98 57.56 FOR AND ON.BEHALF OF THE BOARD PI-ACE : BHOPAL DATEIL3lLLl2o26 M/s 38 BIACKBIO DX tTD (Formerly M/s KILPEST INDIA LTD) REGD.OFFICE: 7-9 INDUSTRIAI AREA,GOVINDPURA, BHOPAT-462 023 CIN:124211MP1972PtC001131 Standalone UnAudited Balance Sheet As On 30-09-2026 in [akhs PARTICUTARS STANDATONE ASSETS As at As at 30-09-2025 31-03-2026 Non-current assets Un-Audited Audited (a) Property, Plant and Equipment 647.09 680.34 (b) Ca pita I work-in-progress 0.00 0.00 (c) Investment Property 0.00 0.00 (d)Goodwill 0.00 0.00 (e) Other Intangible assets 0.00 0.00 (f) Intangible assets under development 0.00 0.00 (g) Biological Assets other than bearer plants 0.00 0.00 (h) Financial Assets 0.00 0.00 (i) Investments 19899.67 18809.84 (ii)Trade receivables 0.00 0.00 (iii) Loans 3r1.57 377.57 (i) Deferred tax assets (net) 0.00 0.00 (j) Other non-current assets 0.00 0.00 Current assets (a) Inventories 554.1s 656.53 (b) Financial Assets 0.00 0.00 (i) Investments 0.00 0.00 (ii)Trade receivables 5687.77 4319.72 (iii) Cash and cash equivalents L392.4t 7679.52 (iv) Bank balances other than(iii) above 7288.Lt 6230.52 (v) Other Financial Assets 19.20 20.42 (vi) Loans 0.00 0.00 (vii) Others (to be specified) 0.00 0.00 (c) Current Tax Assets (Net) 0.00 0.00 (d) Other current assets 7575.70 2329.0O Total Assets 37375.6t 35037.46 EQUITY AND TIABITITIES Equity (a) Equity Share capital 856.84 856.84 (b) Other Equity Equity Attributable to Owners of the Co 33841.07 3ro44.75 Non-Controlli ng I nterest 0.00 0.00 LIABITITIES Non-current liabilities (a) Financial Liabilities 0.00 0.00 (i) Borrowings 0.00 0.00 (ii)Trade payables 0.00 0.00 (iii)Other financial liabilities (other than those specified in item (b), to be specified) 0.00 0.00 (b) Provisions 0.00 0.00 (c) Deferred tax liabilities (Net) 670.34 670.34 (d) Other non-current liabilities 0.00 0.00 Current liabilities (a) Financial Liabilities (i) Borrowings 0.00 0.00 (ii)Trade payables Total outstanding dues of Micro Enterprises and Small Enterprises 37.78 0.00 Total outstanding dues of creditors other than Micro Enterprises and Small Enterprises 7r.26 134.O4 (iii) Other financial liabilities (other than those specified in item (c) 56.70 56.70 (b) Other current liabilities 790.15 674.79 (c) Provisions tosL.47 1600.00 (d) CurrentTax Liabilities (Net) 0.00 0.00 Total Equitv and liabilities 37375.6r 35037.46 PIACE: BHOPAL DATEI L3lLLl2o25 M/s 38 BLACKBIO DX tTD (Formerly M/s KILPEST INDIA LTD) REGD.OFFICE: 7-9 INDUSTRIAI AREA,GOVINDPURA BHOPAt462 023 Cl N :1242 1 1M P1972P1C001131 STANDALONE UNAUDITED STATEMENT OF CASH FIOW FOR THE HAIF YEAR ENDED 3fth SEPTEMBER 2026 (Rs. in Lakhs) For the half year ended For the year ended PARTICUTARS 30th Sept 2026 31st March 2026 Un-Audited Audited CASH FIOW FROM OPERATING ACTIVITIES Net Profit Before Tax & Extra-Ordinary ltems 4258.82 6635.68 Adjustments for: Depreciation 47.OO 94.31 lnterest Paid 0.06 4.39 Unrealised Gain on Investments carried at Fair Value through P&L (3s3.31) (2e7.4O) Operating Profit before working capital changes 3952.57 6435.98 Adjustments for: lnventories 102.38 157.35 Trade and other Receivables (613.47) (1341.3s) Trade Payables and Other Liabilities (4s8.17) 644.62 Cash generated from operations 2983.3L 5897.56 Income tax payments (10s1.47) (1615.49) Net Cash used/ available from Operating Activities (A) 1931.84 4282.O7 CASH FIOW FROM INVESTING ACTIVITIES Purchase / Sale of Fixed Assets (13.7s) (137.se) Acquisition of Investment (Net of Sales) (736.s21, (1842.44) Decrease in other non current assets 0.00 0.00 Net Cash Used in Investing Activities (B) 17so.27l (1e80.03) CASH FLOW F lncrease in non current assets 0.00 (311.s7) Capita I Su bsidy Received 16.77 33.5s lncrease/Decrease in bank borrowings 0.00 0.00 Decrease in Other Non Current Liability 0.00 (30.6e) Increase/Decrease in other borrowings 0.00 0.00 lnterest Paid (0.06) (4.3s) Equity Dividend Paid 1427.801 1342.2s1 Net Cash From Financing activities (C ) (411.0e) (5ss.3s) Net Increase /Decrease in Cash & Cash equivalents (A+B+C) 770.48 {r 1646.69 Cash & Cash equivalents as at 1st April op [Showing first 8,000 characters — download PDF for full document]